Patrick M Dillon

15PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyEnvironmental epidemiologyMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 29, 2025
A Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor-Positive Breast Cancer: The BRACELET-01/PrE0113 Study.

Amy S Clark, Fengmin Zhao, Paula Klein

|Feb 15, 2024
A Pilot Study of the Combination of Entinostat with Capecitabine in Advanced Breast Cancer.

Trish Millard, Christiana Brenin, Clare Humphrey

|Dec 16, 2023
Estrogen receptor positive breast cancer: contemporary nuances to sequencing therapy.

Jenna Schlefman, Christiana Brenin, Trish Millard

|Mar 08, 2023
Systematic review of the management of brain metastases from hormone receptor positive breast cancer.

Shirley Jusino, Camilo E Fadul, Patrick Dillon

|Nov 11, 2022
Replicative Instability Drives Cancer Progression.

Benjamin B Morris, Jason P Smith, Qi Zhang

|May 18, 2022
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial.

Francois-Clement Bidard, Virginia G Kaklamani, Patrick Neven

Pageof 3

Frequent Collaborators

2 joint publications

Christiana M Brenin

2 joint publications

Alberto J Montero

1 joint publications

Joseph Mort

1 joint publications

Harry Bear